medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2022, Number 4

<< Back Next >>

Arch Neurocien 2022; 27 (4)

Evaluación de la escala Status Epilepticus Severity Score (STESS) como predictor de la mortalidad intrahospitalaria en pacientes con estado epiléptico: estudio observacional retrospectivo

Vidal-Mayo JJ, Guzmán-Ramírez U, Hernández-Gilsoul T, Kammar-García A, Pérez-Méndez A, Mancilla-Galindo J

Language: Spanish
References: 27
Page: 23-30
PDF size: 302.65 Kb.


ABSTRACT

No abstract.


REFERENCES

  1. Xu MY. Poststroke seizure: optimising its management. Stroke VascNeurol. 2019; 4(1):48-56. doi:10.1136/svn-2018-000175

  2. Horváth L, Fekete I, Molnár M, Válóczy R, Márton S, Fekete K.The outcome of status epilepticus and long-term follow-up. FrontNeurol. 2019; 10:427. doi:10.3389/fneur.2019.00427

  3. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T,et al. Guidelines for the evaluation and management of statusepilepticus. Neurocrit Care. 2012;17(01):3-23. doi:10.1007/s12028-012-9695-z

  4. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, ShinnarS, et al. A definition and classification of status epilepticus–Reportof the ILAE Task Force on Classification of Status Epilepticus.Epilepsia. 2015;56(10):1515-23. doi:10.1111/epi.13121

  5. Brigo F, Del Giovane C, Nardone R, Trinka E, Lattanzi S.Proceedings of the 3rd London-Innsbruck colloquium on statusepilepticus. Epilepsia. 2011; 52 (S8):1-85. doi:10.1016/j.yebeh.2019.106466

  6. Shorvon S, Ferlisi M. The treatment of super-refractory statusepilepticus: a critical review of available therapies and aclinical treatment protocol. Brain. 2011;134(10):2802-18.doi:10.1093/brain/awr215

  7. Jobst BC, Ben-Menachem E, Chapman KE, Fu A, GoldmanA, Hirsch LJ, et al. Highlights from the Annual Meeting of theAmerican Epilepsy Society. Epilepsy Curr. 2018;19(3):152-8.doi:10.1177/1535759719844486

  8. Delaj L, Novy J, Ryvlin P, Marchi NA, Rossetti AO. Refractoryand super-refractory status epilepticus in adults: a 9-year cohortstudy. Acta Neurol Scand. 2017;135(01):92-9. doi:10.1111/ane.12605

  9. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ,Fitzsimmons BF. Refractory status epilepticus: frequency,risk factors, and impact on outcome. Arch Neurol. 2002;59(02):205-10. doi:10.1001/archneur.59.2.205

  10. Trinka E, Höfler J, Zerbs A. Causes of status epilepticus. Epilepsia2012; 53(S4):127-38. doi:10.1111/j.1528-1167.2012.03622.x

  11. Ferlisi M, Shorvon S. The outcome of therapies in refractoryand super-refractory convulsive status epilepticus andrecommendations for therapy. Brain. 2012;135(8):2314-28.doi:10.1093/brain/aws091

  12. Strzelczyk A, Ansorge S, Hapfelmeier J, Bonthapally V, Erder MH,Rosenow F. Costs, length of stay, and mortality of super-refractorystatus epilepticus: a population-based study from Germany.Epilepsia. 2017; 58(09):1533-41. doi:10.1111/epi.13837

  13. Rossetti AO, Logroscino G, Bomfield EB. A clinical score forprognosis of status epilepticus in adults. Neurology. 2006;1736-8. doi:10.1212/01.wnl.0000223352.71621.97

  14. Valdés-Galván RE, González-Calderón G, Castro-MartínezE. Epidemiología del descontrol de la epilepsia en un serviciode urgencias neurológicas. Rev Neurol. 2019; 68:321-5.doi:10.33588/rn.6808.2018218.

  15. Sutter R, Kaplan PW, Rüegg S. Independent external validationof the Status Epilepticus Severity Score. Crit Care Med. 2013;41(12):475-9. doi:10.1097/CCM.0b013e31829eca06

  16. Lettinger M, Kalss G, Rohracher A, Pilz G, Novak H, Höfler J,et al. Predicting outcome of status epilepticus. Epilepsy Behav.2015;49:126-30. doi:10.1016/j.yebeh.2015.04.066

  17. Kang B, Kim D, Kim K, Moon H, Kim Y, Kim H, et al. Predictionof mortality and functional outcome from status epilepticus andindependent external validation of STESS and EMSE scores. CritCare. 2015; 20(1):1-8.

  18. Aukland P, Lando M, Vilholm O, Christiansen EB, Beier CP.Predictive value of the Status Epilepticus Severity Score (STESS)and its components for long-term survival. BMC Neurol. 2016;16(1):213.

  19. Millán Sandoval JP, Escobar Del Rio LM, Gómez EA, Ladino LD,Ospina LML, Díaz DM, et al. Validation of the Status epilepticusseverity score (STESS) at high-complexity hospitals in Medellín,Colombia. Seizure. 2020; 81:287-91.

  20. Rossetti AO, Logroscino G, Milligan TA, Michaelides C, RuffieuxC, Bromfield EB. Status Epilepticus Severity Score (STESS):a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561-6.

  21. Leitinger M, Kalss G, Rohracher A, Pilz G, Novak H, Höfler J, et al. Epidemiology based-mortality score in status epilepticus (EMSE).Neurocrit Care. 2015;22(2):273-82. doi:10.1007/s12028-014-0080-y

  22. Peng P, Peng J, Yin F, Deng X, Chen C, He F. Ketogenic diet as a treatment for super-refractory status epilepticus in febrile infection-relatedepilepsy syndrome. Front Neurol. 2019;10:423. doi:10.3389/fneur.2019.00423

  23. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurologicalintensive care unit. J Neurol Neurosurg Psychiatry. 2005;76:534-9. doi:10.1136/jnnp.2004.041947

  24. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol.2005;62:1698-702. doi:10.1001/archneur.62.11.1698

  25. Ramos AB, Cruz RA, Villemarette-Pittman NR, Olejniczak PW, Mader EC. Dexamethasone as abortive treatment for refractoryseizures or status epilepticus in the inpatient setting. J Investig Med High Impact Case Rep. 2019; 7:2324709619848816.doi:10.1177/2324709619848816

  26. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251-6.doi:10.1111/j.1528-1167.2009.02323.x

  27. Mayer SA, Classen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors and impact onoutcome. Arch Neurol. 2002;59:205-10. doi:10.1001/archneur.59.2.205




2020     |     www.medigraphic.com